Study details
Enrolling now
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
National Cancer Institute (NCI)
NCT IDNCT05691517ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Ages
18+
Locations
1 site in MD
What this study is about
This Phase 1 study is focused on people with advanced malignant solid neoplasm.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
biopsy, diagnostic, imaging